Definitive Contract 75N93019C00033

Award Date 8/26/19
Potential Completion Date 8/31/20
Potential Value $150K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Redondo Beach, CA 90278, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This definitive contract from the National Institutes of Health's National Cancer Institute, valued at $398,001, was awarded to Ferrologix Inc. to address Topic 397 under a Small Business Innovation Research Program Phase I solicitation. Specifically, the prime contractor will conduct research and development to functionally close the purification and elution of untouched T cells using cleavable magnetic beads with ratcheting cytometry. This firm fixed price contract has a period of...
This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The contract, valued at $5,550.00, is for the delivery and installation of specialized laboratory equipment and related reagents and consumables. This includes flow cytometers, cell sorters, tissue dissociators, and automated cell separation systems, as well as proprietary reagents and...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The $14,577 firm-fixed-price purchase order is for the supply of microbeads and columns for the MACS cell separation system, which is used to support biomedical research and cell therapy development programs at the NIH Clinical Center. This award is part of a larger indefinite...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The $10,594.50 firm fixed-price purchase order was awarded to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research and cell therapy development. The contract requires Miltenyi Biotec to deliver various cell...
This federal contract award is for the procurement of a BIOFLUX 200 WITH PLATES from Cell Microsystems, Inc. by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID). The $13,810.00 firm fixed price purchase order has a performance period ending on July 17, 2024. Cell Microsystems, a for-profit manufacturer, has previously provided biomedical equipment and supplies for infectious disease research, cancer...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), awarded a Firm Fixed Price Purchase Order contract worth $23,883.00 to Research And Diagnostic Systems, Inc. (R&D Systems), a subsidiary of Bio-Techne Corporation. The contract is for the delivery of PREMIXED MAGNETIC LUMINEX PERFORMANCE ASSAY KITS, which are specialized laboratory reagents and instruments used in biomedical research applications,...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Standard Biotools Inc., doing business as Fluidigm. The $7,380 firm-fixed-price purchase order is for Fluidigm's C1 single-cell auto-prep system for mRNA analysis. The contract is set aside for small businesses. Fluidigm, a for-profit manufacturer of specialized scientific instruments and reagents, has an extensive history of providing...
This $6,929.75 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized instruments, reagents, and services for biomedical research and cell therapy development. The contract does not have a set-aside designation. Miltenyi Biotec is delivering a range of products and services to support NIAID's research programs, particularly in areas such as cancer,...
This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Miltenyi Biotec, Inc., a global biotechnology company. The contract is a $45,316 firm fixed-price purchase order for an "Automacs Pro Separator Starter Kit." It does not have a set-aside designation. The contract supports NIAID's biomedical research programs, particularly in areas such as cancer, immunology, and...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. The $12,810 contract provides for the delivery of specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. Key deliverables include flow cytometers, cell sorters, tissue dissociators, automated cell...

This contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Ferrologix Inc., a small disadvantaged business, to provide research, development, and production services related to a sample sparring assay for isolation and analysis of immune cell populations using magnetic ratcheting. The firm fixed price contract has a potential value of $149,931.00 and was completed on August 31, 2020. Ferrologix has previously been awarded NIH contracts and grants to develop magnetic bead-based cell sorting and isolation platforms for immunotherapy and cell therapy applications. This contract supports the continued advancement of Ferrologix's magnetic ratcheting cytometry technology, which enables high throughput, parallelized cell isolation.

Generated 3/24/24, 12:53 AM